UK markets closed

Community Health Systems, Inc. (CYH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
3.3050-0.1350 (-3.92%)
As of 03:42PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 478.04M
Enterprise value 12.66B
Trailing P/E 16.89
Forward P/E 10.14
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.04
Price/book (mrq)N/A
Enterprise value/revenue 1.01
Enterprise value/EBITDA 8.18

Trading information

Stock price history

Beta (5Y monthly) 1.55
52-week change 3-4.18%
S&P500 52-week change 323.57%
52-week high 35.2000
52-week low 32.0100
50-day moving average 33.0312
200-day moving average 33.1814

Share statistics

Avg vol (3-month) 32.18M
Avg vol (10-day) 32.32M
Shares outstanding 5138.97M
Implied shares outstanding 6138.97M
Float 898.22M
% held by insiders 18.19%
% held by institutions 171.58%
Shares short (15 Apr 2024) 46.5M
Short ratio (15 Apr 2024) 42.93
Short % of float (15 Apr 2024) 45.17%
Short % of shares outstanding (15 Apr 2024) 44.68%
Shares short (prior month 15 Mar 2024) 47.41M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 328 Dec 2012
Ex-dividend date 413 Dec 2012
Last split factor 2121:100
Last split date 322 Apr 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.98%
Operating margin (ttm)7.90%

Management effectiveness

Return on assets (ttm)4.00%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)12.52B
Revenue per share (ttm)95.70
Quarterly revenue growth (yoy)1.00%
Gross profit (ttm)N/A
EBITDA 1.34B
Net income avi to common (ttm)-123M
Diluted EPS (ttm)-0.9400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)48M
Total cash per share (mrq)0.36
Total debt (mrq)12.23B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.49
Book value per share (mrq)-10.79

Cash flow statement

Operating cash flow (ttm)301M
Levered free cash flow (ttm)-53.25M